4.7 Review

Multiple functions of USP18

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

ISG15 deficiency and increased viral resistance in humans but not mice

Scott D. Speer et al.

NATURE COMMUNICATIONS (2016)

Editorial Material Biochemistry & Molecular Biology

Poised for action: USP18 restrains microglial activation in the white matter

Kazuyuki Takata et al.

EMBO JOURNAL (2015)

Article Biochemistry & Molecular Biology

USP18 lack in microglia causes destructive interferonopathy of the mouse brain

Tobias Goldmann et al.

EMBO JOURNAL (2015)

Article Multidisciplinary Sciences

USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2

Jamshed Warsi et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance

Lars Ketscher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Medicine, General & Internal

Novel Combination Markers for Predicting Survival in Patients with Muscle Invasive Bladder Cancer: USP18 and DGCR2

Ye-Hwan Kim et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2014)

Article Biochemistry & Molecular Biology

USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity

Bangxing Hong et al.

MOLECULAR CANCER (2014)

Review Immunology

Regulation of type I interferon responses

Lionel B. Ivashkiv et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Review Endocrinology & Metabolism

Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and β-cell apoptosis

I. Santin et al.

DIABETES OBESITY & METABOLISM (2013)

Article Clinical Neurology

Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment

S. Malhotra et al.

EUROPEAN JOURNAL OF NEUROLOGY (2013)

Article Oncology

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Mohammad Shahidul Makki et al.

EXPERIMENTAL CELL RESEARCH (2013)

Editorial Material Immunology

Mechanisms of sterile inflammation

Anna Rubartelli et al.

FRONTIERS IN IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-α/β-mediated apoptosis in Ubp43-deficient hematopoietic cells

Hwa Young Yim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Article Biochemistry & Molecular Biology

USP18 establishes the transcriptional and anti-proliferative interferon α/β differential

Veronique Francois-Newton et al.

BIOCHEMICAL JOURNAL (2012)

Article Biochemistry & Molecular Biology

Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus

Christoph Burkart et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Immunology

Usp18 Promotes Conventional CD11b+ Dendritic Cell Development

Xiu-Li Cong et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Oncology

Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target

Yongli Guo et al.

MOLECULAR CANCER THERAPEUTICS (2012)

Article Biochemistry & Molecular Biology

Type I IFNs signaling and apoptosis resistance in glioblastoma cells

Andrea Sgorbissa et al.

APOPTOSIS (2011)

Article Biochemistry & Molecular Biology

Rickettsia conorii infection stimulates the expression of ISG15 and ISG15 protease UBP43 in human microvascular endothelial cells

Punsiri M. Colonne et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Biochemistry & Molecular Biology

Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7

Jason E. Duex et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Multidisciplinary Sciences

Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis

Sunny Malhotra et al.

PLOS ONE (2011)

Review Immunology

Type I interferon: friend or foe?

Giorgio Trinchieri

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Review Biochemistry & Molecular Biology

Critical Review: Assessment of Interferon-beta Immunogenicity in Multiple Sclerosis

Klaus Bendtzen

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)

Article Biochemistry & Molecular Biology

Dissection of USP catalytic domains reveals five common insertion points

Yu Ye et al.

MOLECULAR BIOSYSTEMS (2009)

Article Oncology

UBE1L causes lung cancer growth suppression by targeting cyclin D1

Qing Feng et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Article Biochemistry & Molecular Biology

Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages

Weiguo Zou et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Endocrinology & Metabolism

Ubp43 gene expression is required for normal Isg15 expression and fetal development

Lea A. Rempel et al.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2007)

Article Multidisciplinary Sciences

IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses

Deborah J. Lenschow et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Gastroenterology & Hepatology

Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection

Glenn Randall et al.

GASTROENTEROLOGY (2006)

Review Oncology

Ubiquitin and ubiquitin-like proteins in cancer pathogenesis

Daniela Hoeller et al.

NATURE REVIEWS CANCER (2006)

Article Biochemistry & Molecular Biology

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

Oxana A. Malakhova et al.

EMBO JOURNAL (2006)

Article Biochemistry & Molecular Biology

The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase

WG Zou et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Multidisciplinary Sciences

Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15

A Okumura et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling

KI Kim et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Article Biochemistry & Molecular Biology

Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice

KP Knobeloch et al.

MOLECULAR AND CELLULAR BIOLOGY (2005)

Review Biochemistry & Molecular Biology

ISG15: A ubiquitin-like enigma

CT Dao et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2005)

Review Cell Biology

ISG15: the immunological kin of ubiquitin

KJ Ritchie et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)

Article Biochemistry & Molecular Biology

Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection

KJ Ritchie et al.

NATURE MEDICINE (2004)

Article Biochemistry & Molecular Biology

The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase

S Tokarz et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation

KI Kim et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)

Article Multidisciplinary Sciences

The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein

C Zhao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Cell Biology

Protein ISGylation modulates the JAK-STAT signaling pathway

OA Malakhova et al.

GENES & DEVELOPMENT (2003)

Article Cell Biology

Dysregulation of protein modification by ISG15 results in brain cell injury

KJ Ritchie et al.

GENES & DEVELOPMENT (2002)

Article Biochemistry & Molecular Biology

UBP43 (USP18) specifically removes ISG15 from conjugated proteins

MP Malakhov et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Medicine, General & Internal

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.

LD Jacobs et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)